WallStreetZenWallStreetZen

NASDAQ: LUCD
Lucid Diagnostics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for LUCD

Based on 3 analysts offering 12 month price targets for Lucid Diagnostics Inc.
Min Forecast
$2.50+82.48%
Avg Forecast
$3.50+155.47%
Max Forecast
$4.00+191.97%

Should I buy or sell LUCD stock?

Based on 3 analysts offering ratings for Lucid Diagnostics Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LUCD stock forecasts and price targets.

LUCD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-14
lockedlocked$00.00+00.00%2023-09-26
lockedlocked$00.00+00.00%2023-08-22

1 of 1

Forecast return on equity

Is LUCD forecast to generate an efficient return?
Company
-2,638.8%
Industry
14.87%
Market
-21.53%
LUCD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LUCD forecast to generate an efficient return on assets?
Company
-202.89%
Industry
7.95%
LUCD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LUCD vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
LUCD$1.37$3.50+155.47%Strong Buy
CTSO$1.28$4.75+271.09%Strong Buy
DCTH$2.98$18.00+504.03%Strong Buy
NSPR$2.57$4.50+75.10%Strong Buy
EAR$2.59N/AN/A
View Top Medical Device Stocks

Lucid Diagnostics Stock Forecast FAQ

Is Lucid Diagnostics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: LUCD) stock is to Strong Buy LUCD stock.

Out of 3 analysts, 2 (66.67%) are recommending LUCD as a Strong Buy, 1 (33.33%) are recommending LUCD as a Buy, 0 (0%) are recommending LUCD as a Hold, 0 (0%) are recommending LUCD as a Sell, and 0 (0%) are recommending LUCD as a Strong Sell.

If you're new to stock investing, here's how to buy Lucid Diagnostics stock.

What is LUCD's forecast return on equity (ROE) for 2023-2023?

(NASDAQ: LUCD) forecast ROE is -2,638.8%, which is considered weak.

What is LUCD's Price Target?

According to 3 Wall Street analysts that have issued a 1 year LUCD price target, the average LUCD price target is $3.50, with the highest LUCD stock price forecast at $4.00 and the lowest LUCD stock price forecast at $2.50.

On average, Wall Street analysts predict that Lucid Diagnostics's share price could reach $3.50 by Nov 14, 2024. The average Lucid Diagnostics stock price prediction forecasts a potential upside of 155.47% from the current LUCD share price of $1.37.

What is LUCD's forecast return on assets (ROA) for 2023-2023?

(NASDAQ: LUCD) forecast ROA is -202.89%, which is lower than the forecast US Medical Devices industry average of 7.95%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.